Back to top

Astellas Pharma (ALPMF) Receives a Hold from UBS

UBS analyst maintained a Hold rating on Astellas Pharma today and set a price target of Yen2,300.00. In a report released on July 7, Bernstein also...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astellas Pharma Inc. (ALPMY)